BrainsWay to Report Fourth Quarter and Full Year 2025 Financial Results on March 11, 2026
BrainsWay (NASDAQ: BWAY) will report its fourth quarter and full year 2025 financial results on Wednesday, March 11, 2026 before U.S. markets open.
Rhea-AI Summary
BrainsWay (NASDAQ: BWAY) will report its fourth quarter and full year 2025 financial results on Wednesday, March 11, 2026 before U.S. markets open. A conference call and webcast will be held at 8:30 AM ET to discuss results and operational highlights.
Dial-in numbers, a webcast link, and a Conference ID are provided; the live broadcast will be available for replay for 30 days on the company investor website.
Positive
- None.
Negative
- None.
Details
News Market Reaction – BWAY
On Feb 25, the day this news came out, BWAY closed 0.16% above the previous close.
Data tracked by StockTitan Argus for the Feb 25 session.
Key Figures
- Earnings date
- March 11, 2026
- Scheduled fourth quarter and full year 2025 results release
- Conference time
- 8:30 AM Eastern Time
- Start time for results conference call and webcast
- US dial-in
- 1-877-300-8521
- United States conference call number
- International dial-in
- 1-412-317-6026
- International conference call number
- Israel dial-in
- 1-80-921-2373
- Israel conference call number
- Conference ID
- 10206784
- Access code for the earnings conference call
- Replay period
- 30 days
- Replay availability for webcast on company website
Historical Context
-
Announcement of participation in Citi MedTech and Life Sciences Access Day.
-
Minority-stake equity financing in BrainStim Health with milestone-based tranches.
-
Evernorth to remove prior authorization for TMS coverage, expanding access.
-
Change in ADS-to-ordinary share ratio equivalent to a 2-for-1 ADS split.
-
Highmark draft policy for accelerated Deep TMS with strong response/remission data.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BURLINGTON, Mass. and JERUSALEM, Feb. 25, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation technologies, today announced that it will report its fourth quarter and full year 2025 financial results, as well as operational highlights, before the open of the U.S. financial markets on Wednesday, March 11, 2026. The Company will host a conference call and webcast at 8:30 AM Eastern Time to discuss the results and provide an update on business operations.
Conference Call Dial-In & Webcast Information
| Date: | Wednesday, March 11, 2026 |
| Time: | 8:30 AM Eastern Time |
| United States: | 1-877-300-8521 |
| International: | 1-412-317-6026 |
| Israel: | 1-80-921-2373 |
| Conference ID: | 10206784 |
| Webcast: | Link |
The conference call will be broadcast live and will be available for replay for 30 days on the Company’s website, https://investors.brainsway.com/events-and-presentations/event-calendar. Please access the Company’s website at least 10 minutes ahead of the conference call to register.
About BrainsWay
BrainsWay is a global leader in advanced noninvasive neurostimulation treatments for mental health disorders. The Company is boldly advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS™) platform technology to improve health and transform lives. BrainsWay is the first and only TMS company to obtain three FDA-cleared indications backed by pivotal clinical studies demonstrating clinically proven efficacy. Current indications include major depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. The Company is dedicated to leading through superior science and building on its unparalleled body of clinical evidence. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. Founded in 2003, with operations in the United States and Israel, BrainsWay is committed to increasing global awareness of and broad access to Deep TMS. For the latest news and information about BrainsWay, please visit www.brainsway.com.
Contacts:
BrainsWay:
Ido Marom
Chief Financial Officer
Ido.Marom@BrainsWay.com
Investors:
Brian Ritchie
LifeSci Advisors
britchie@lifesciadvisors.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.